flufenamic acid has been researched along with Osteoporosis, Postmenopausal in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postmenopausal osteoporosis is one of the most common types of osteoporosis resulting from estrogen deficiency in elderly women." | 1.56 | Flufenamic acid inhibits osteoclast formation and bone resorption and act against estrogen-dependent bone loss in mice. ( Huo, S; Li, H; Nie, B; Qu, X; Tang, H; Yue, B; Zhang, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, S | 1 |
| Huo, S | 1 |
| Li, H | 1 |
| Tang, H | 1 |
| Nie, B | 1 |
| Qu, X | 1 |
| Yue, B | 1 |
1 other study available for flufenamic acid and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Flufenamic acid inhibits osteoclast formation and bone resorption and act against estrogen-dependent bone loss in mice.
Topics: Animals; Anti-Inflammatory Agents; Bone Density; Bone Resorption; Cell Differentiation; Disease Mode | 2020 |